Michael Fossel, President and Founder, Telocyte
Dr. Fossel received his PhD in neurobiology and his MD at Stanford. He published the first articles in the medical literature (JAMA) as well as the first medical textbook, Cells, Aging, and Human Disease on the potential for effective interventions in age-related disease. An extensive look at the field, it includes in-depth discussions of Alzheimer’s disease, the progerias, atherosclerosis, osteoporosis, immune senescence, skin aging, and cancer, as well as the prospects for telomerase therapy. His book, The Telomerase Revolution, was praised by the Wall Street Journal as one of the best science books of the year. A recent article in Alzheimer’s & Dementia on age-related neurodegenerative disease (A unified model of dementias and age‐related neurodegeneration) generated more than 600 global reprint requests and outlines the model currently driving the work at Telocyte. He served as the executive director of the American Aging Association, has published more than 100 articles, books, and chapters on age-related disease and the potential for effective intervention via gene therapy, as well as have served as both an advisor to and board member for several biotechnology companies prior to Telocyte.